Who are SkQ1 Vehicle Solution's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): SkQ1 Ophthalmic Solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/skq1-vehicle-solution.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

SkQ1 Vehicle Solution — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SkQ1 Vehicle Solution (SkQ1 Vehicle Solution) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Mitochondrially-targeted antioxidant. Area: Ophthalmology, Cardiology.

phase 3 Mitochondrially-targeted antioxidant Mitochondrial targeting sequence Ophthalmology, Cardiology Small molecule Live · refreshed every 30 min

Target snapshot

SkQ1 Vehicle Solution (SkQ1 Vehicle Solution) — Mitotech, SA. SkQ1 is a mitochondrially-targeted antioxidant that aims to delay the onset of age-related diseases.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
SkQ1 Vehicle Solution TARGET	SkQ1 Vehicle Solution	Mitotech, SA	phase 3	Mitochondrially-targeted antioxidant	Mitochondrial targeting sequence
SkQ1 Ophthalmic Solution	SkQ1 Ophthalmic Solution	Mitotech, SA	phase 3	Mitochondrially-targeted antioxidant	Mitochondrial electron transport chain

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Mitochondrially-targeted antioxidant class)

Mitotech, SA · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SkQ1 Vehicle Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/skq1-vehicle-solution. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing